rhenium has been researched along with Carcinoma, Hepatocellular in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 21 (51.22) | 29.6817 |
| 2010's | 20 (48.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z | 1 |
| Bhusari, P; Chhabra, A; Duseja, A; Kalra, N; Kumar, R; Mittal, BR; Parmar, M; Shukla, J; Singh, H; Vatsa, R | 1 |
| Bokharaei, M; De La Vega, JC; Esquinas, PL; Häfeli, UO; Liu, D; Moskalev, I; Rodríguez-Rodríguez, C; Saatchi, K | 1 |
| Huang, PW; Kao, CH; Lin, WY; Luo, TY; Tsai, SC | 1 |
| Ardisson, V; Audrain, O; Boucher, E; Clement, B; Edeline, J; Garin, E; Lenoir, L; Lepareur, N; Pracht, M; Raoul, JL | 1 |
| Lin, WJ; Lin, XZ; Luo, TY; Peng, CL; Shieh, MJ; Shih, YH; Yeh, CH | 1 |
| Chang, CH; Chen, LC; Chen, SJ; Chuang, CH; Ho, CL; Lee, TW; Lee, WC; Lin, CH; Ni, HC; Yu, CY | 1 |
| Chiang, PF; Lin, WJ; Luo, TY; Peng, CL; Shieh, MJ; Shih, YH | 1 |
| El-Kawy, OA; Talaat, HM | 1 |
| Bernard, C; Couturier, O; Drion, P; Duwez, L; Hindré, F; Hustinx, R; Lacoeuille, F; Lepareur, N; Meffre, G; Verger, E | 1 |
| Chang, CH; Chang, YJ; Chen, LC; Chen, SJ; Lee, TW; Lee, WC; Shien, JH | 1 |
| Arteaga de Murphy, C; Ferro-Flores, G | 1 |
| Antoch, G; Gerken, G; Haberkorn, U; Hamami, M; Hilgard, P; Müller, S; Sauerwein, WS | 1 |
| Bacher, K; Defreyne, L; Lambert, B | 1 |
| Banzato, A; Mazzi, U; Meléndez-Alafort, L; Nadali, A; Rondina, M; Rosato, A; Zangoni, E | 1 |
| Chen, CY; Kung, HC; Lin, WJ; Lin, XZ; Luo, TY; Shih, YH; Tang, IC; Wu, YL | 1 |
| de Murphy, CA; Jung-Cook, H; Molina-Trinidad, EM; Morales-Marquez, JL; Pedraza-Lopez, M; Serrano, GV; Stack, EM | 1 |
| Boucher, E; Edeline, J; Garin, E; Pracht, M; Raoul, JL; Rolland, Y | 1 |
| Aubé, C; Benoît, JP; Bouchet, F; Couturier, O; Garcion, E; Garin, E; Hindré, F; Lacoeuille, F; Lepareur, N; Noiret, N; Oberti, F; Roux, J; Vanpouille-Box, C | 1 |
| Anton, M; Göke, B; Klutz, K; Senekowitsch-Schmidtke, R; Spitzweg, C; Willhauck, MJ; Wunderlich, N; Zach, C | 1 |
| Chan, SH; Chang, Y; Kung, HC; Lin, WJ; Lin, WY; Liu, SW; Luo, TY; Peng, CL; Tang, IC | 1 |
| Ardisson, V; Garin, E; Laffont, S; Lepareur, N; Noiret, N | 1 |
| Liu, Q; Xie, T; Zaidi, H | 1 |
| Dash, A; Knapp, FF; Pillai, MR | 1 |
| Huang, PW; Kao, CH; Lin, WY; Luo, TY; Tang, IC; Tsai, SC | 1 |
| Cheng, H; Gao, Y; Shi, L; Wu, M; Zhang, Z; Zhuang, D | 1 |
| Bacher, K; de Ridder, L; De Ruyck, K; De Vos, F; Dierckx, RA; Gemmel, F; Lambert, B; Thierens, H; Vral, A | 1 |
| Bernal, P; Chau, TC; Onkhuudai, P; Padhy, AK; Sundram, F | 1 |
| Huang, YS; Hung, GU; Lee, JC; Lin, WY; Lin, YC; Tsai, SC | 1 |
| Benoit, JP; Bourguet, P; Denizot, B; Garin, E; Herry, JY; Laurent, JF; Lejeune, JJ; Lepareur, N; Mesba, H; Moreau, M; Noiret, N; Roux, J | 1 |
| Acharya, SK; Bal, C; Duttagupta, S; Kumar, A; Sharma, S; Srivastava, DN; Thulkar, SP | 1 |
| Bal, C; Kumar, A; Srivastava, DN | 1 |
| de Gelder, V; De Ridder, L; De Vos, F; Lambert, B; Slegers, G; Thierens, H; Van de Wiele, C | 1 |
| Hobbelink, MG; Nijsen, JF; van Het Schip, AD; Vente, MA; Zonnenberg, BA | 1 |
| Bernal, P; Buscombe, J; Chen, S; Divgi, C; Jeong, JM; Kumar, A; Minh, CT; Ogbac, R; Padhy, AK; Pusuwan, P; Raoul, JL; Saw, MM; Sereegotov, E; Stare, J; Sundram, FX; Vidmar, G; Zanzonico, P | 1 |
| Brogsitter, C; Folprecht, G; Hliscs, R; Kotzerke, J; Leonhard, J; Liepe, K; Pinkert, J; Wunderlich, G | 1 |
| Bernal, P; Buscombe, J; Chau, TT; Chen, S; Divgi, C; Dondi, M; Jeong, JM; Kumar, A; Ogbac, R; Padhy, AK; Pusuwan, P; Raoul, JL; Saw, MM; Sereegotov, E; Stare, J; Sundram, FX; Vidmar, G; Zanzonico, P | 1 |
| Gates, VL; Ibrahim, SM; Kulik, L; Lewandowski, RJ; Mulcahy, MF; Omary, RA; Ryu, RK; Salem, R; Sato, KT | 1 |
| Bian, HJ; Chen, ZN; Li, J; Lou, C; Zhou, SB | 1 |
| London, L | 1 |
| Htoo, MM; Keng, GH; Kwok, R; Oon, CJ; Premaraj, J; Somanesan, S; Sundram, FX; Yu, SW | 1 |
8 review(s) available for rhenium and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, Physiological; Adipates; Administration, Oral; Adolescent; Adrenal Glands; Adsorption; Adult; Aged; Aged, 80 and over; Aging; AIDS-Related Opportunistic Infections; Aldosterone; Amino Acids; Ammonia; Amoxicillin; AMP-Activated Protein Kinases; Animals; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Antirheumatic Agents; Apgar Score; Area Under Curve; ARNTL Transcription Factors; Arterial Pressure; Arthritis, Juvenile; Athletes; Attention; Biodegradation, Environmental; Biofilms; Biofuels; Biological Therapy; Biomass; Biomimetic Materials; Bioreactors; Birth Weight; Bismuth; Blood Flow Velocity; Bone and Bones; Brain Injuries, Traumatic; Calcium; Calcium Channels; Capsaicin; Carbon; Carcinoma, Hepatocellular; Cardiomegaly, Exercise-Induced; Cartilage; Cartilage, Articular; Case-Control Studies; Catalysis; Cats; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Charcoal; Chemokine CCL2; Child; Child, Preschool; Chondrogenesis; Chronic Disease; Circadian Clocks; Circadian Rhythm Signaling Peptides and Proteins; Clarithromycin; Coccidioides; Coccidioidomycosis; Cognitive Behavioral Therapy; Coinfection; Color; Coloring Agents; Computer Simulation; Computers, Molecular; Consensus; Corticosterone; Cyclic AMP Response Element-Binding Protein; Cytochrome P-450 Enzyme System; Death, Sudden, Cardiac; Density Functional Theory; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dialysis Solutions; Disease Models, Animal; Dogs; Dopamine Agonists; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Electrolytes; Endocardium; Endocrine Disruptors; Endocytosis; Endoscopy, Gastrointestinal; Escherichia coli Proteins; Esters; Evolution, Molecular; Executive Function; Feasibility Studies; Female; Ferric Compounds; Fluorescence; Fluorescent Dyes; Fluorine Radioisotopes; Frailty; Free Radical Scavengers; Gabapentin; Geriatric Assessment; Glucaric Acid; Glucocorticoids; Glucose; Glucose Metabolism Disorders; Halogenated Diphenyl Ethers; Heart Rate; Heart Ventricles; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hep G2 Cells; Hepatocytes; Humans; Hungary; Hydrogen Sulfide; Hydrogen-Ion Concentration; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Independent Living; Indocyanine Green; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Inflorescence; Insulin Resistance; Insulins; International Agencies; Iron; Isotonic Solutions; Kidney Failure, Chronic; Kinetics; Lactones; Leukocytes, Mononuclear; Liver Neoplasms; Macular Edema; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetosomes; Male; Medical Audit; Mesenchymal Stem Cells; Metabolic Syndrome; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Middle Aged; Molecular Conformation; Molecular Targeted Therapy; Motor Activity; Multiple Sclerosis; Mycophenolic Acid; Netherlands; Neuropsychological Tests; Nuclear Energy; Organs at Risk; Osteoarthritis; Osteoarthritis, Hip; Oxidation-Reduction; Palladium; Pericardium; Perinatal Death; Peritoneal Dialysis; Phantoms, Imaging; Pharmaceutical Preparations; Phospholipids; Phosphorylation; Physical Conditioning, Human; Physical Endurance; Pilot Projects; Polyketides; Polymers; Positron-Emission Tomography; Postoperative Period; Potassium; Powders; Pramipexole; Predictive Value of Tests; Pregabalin; Pregnancy; Pregnancy Outcome; Protein Structure, Secondary; Proton Pump Inhibitors; Puberty; Pulmonary Circulation; Quality Assurance, Health Care; Quantum Dots; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rats, Sprague-Dawley; Receptors, CCR2; Receptors, Transferrin; Regeneration; Registries; Renal Insufficiency, Chronic; Reproducibility of Results; Research Design; Restless Legs Syndrome; Retina; Retinoid X Receptor alpha; Retrospective Studies; Rhenium; Risk Factors; RNA, Messenger; Severity of Illness Index; Sex Factors; Sodium; Sodium Fluoride; Solvents; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Stroke; Structure-Activity Relationship; Tachycardia, Ventricular; Tetracycline; Tetrahydrofolate Dehydrogenase; Tetrahydronaphthalenes; Thermodynamics; Thiophenes; Time Factors; Tinidazole; Tomography, Optical Coherence; Tomography, X-Ray Computed; Topiramate; Toxoplasma; Toxoplasmosis, Cerebral; Transferrin; Treatment Outcome; Up-Regulation; Upper Extremity; Uremia; Uveitis; Vascular Remodeling; Ventricular Fibrillation; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling; Verapamil; Veterans; Visual Acuity; Vitrectomy; Water Pollutants, Chemical; Zea mays; Zirconium | 2019 |
Pharmacokinetics and dosimetry of 188 Re-pharmaceuticals.
Topics: Bone Neoplasms; Carcinoma, Hepatocellular; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Microspheres; Neoplasms; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium | 2008 |
[Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].
Topics: Algorithms; Brachytherapy; Carcinoma, Hepatocellular; Diagnostic Imaging; Embolization, Therapeutic; Humans; Iodine Radioisotopes; Iodized Oil; Liver Function Tests; Liver Neoplasms; Microspheres; Neovascularization, Pathologic; Radiation Tolerance; Radioisotopes; Radiotherapy Dosage; Rhenium; Yttrium Radioisotopes | 2009 |
Rhenium-188 based radiopharmaceuticals for treatment of liver tumours.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium | 2009 |
[Radioembolisation for hepatocellular carcinoma].
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Embolization, Therapeutic; Ethiodized Oil; Humans; Liver Neoplasms; Microspheres; Radioisotopes; Rhenium; Yttrium Radioisotopes | 2011 |
Rhenium-188: availability from the (188)W/(188)Re generator and status of current applications.
Topics: Adsorption; Antibodies, Monoclonal; Arthritis, Rheumatoid; Bone Neoplasms; Carcinoma, Hepatocellular; Chromatography; Coronary Disease; Drug Combinations; Equipment Design; Humans; Iodized Oil; Liver Neoplasms; Musculoskeletal Pain; Neoplasms; Organometallic Compounds; Palliative Care; Peptides; Radioimmunotherapy; Radioisotopes; Radionuclide Generators; Radiopharmaceuticals; Rhenium; Skin Neoplasms; Succimer | 2012 |
Radionuclide liver cancer therapies: from concept to current clinical status.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Disease Models, Animal; Drug Delivery Systems; Holmium; Humans; Iodine Radioisotopes; Liver; Liver Neoplasms; Microspheres; Prognosis; Radiopharmaceuticals; Rhenium; Yttrium Radioisotopes | 2007 |
Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Microspheres; Radiation Dosage; Radioisotopes; Radiopharmaceuticals; Rhenium; Treatment Outcome; Yttrium Radioisotopes | 2008 |
7 trial(s) available for rhenium and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
[Radiotherapy with (186)Re-lipiodol II for primary liver cancer patients].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Drug Carriers; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium; Treatment Outcome | 2002 |
Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Body Burden; Carcinoma, Hepatocellular; Chromosome Aberrations; Chromosomes; Cohort Studies; Dose-Response Relationship, Radiation; Female; Humans; Iodine Radioisotopes; Iodized Oil; Liver Neoplasms; Lymphocytes; Male; Middle Aged; Radiation Injuries; Radioisotopes; Radiometry; Relative Biological Effectiveness; Rhenium; Whole-Body Counting | 2004 |
Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Colombia; Feeding and Eating Disorders; Female; Fever; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mongolia; Pilot Projects; Radiopharmaceuticals; Rhenium; Singapore; Survival Analysis; Treatment Outcome; Vietnam | 2004 |
Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA-sponsored multination study.
Topics: Adult; Aged; Aged, 80 and over; Bilirubin; Biomarkers; Carcinoma, Hepatocellular; Female; Humans; Injections, Intra-Arterial; Iodized Oil; Liver Cirrhosis; Liver Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Radioisotopes; Regression Analysis; Remission Induction; Rhenium; Statistics, Nonparametric | 2007 |
Feasibility of high activity rhenium-188-microsphere in hepatic radioembolization.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Colorectal Neoplasms; Embolization, Therapeutic; Feasibility Studies; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Rhenium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
International Atomic Energy Agency-sponsored multination study of intra-arterial rhenium-188-labeled lipiodol in the treatment of inoperable hepatocellular carcinoma: results with special emphasis on prognostic value of dosimetric study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Humans; Injections, Intra-Arterial; International Agencies; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Nuclear Energy; Prognosis; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Rhenium | 2008 |
Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease-Free Survival; Follow-Up Studies; Hepatectomy; Humans; Infusions, Intra-Arterial; Iodine Radioisotopes; Iodized Oil; Liver Neoplasms; Microspheres; Neoplasm Staging; Palliative Care; Postoperative Care; Prognosis; Radioisotopes; Radiopharmaceuticals; Radiotherapy, Adjuvant; Rhenium; Singapore; Treatment Outcome; Yttrium Radioisotopes | 2002 |
26 other study(ies) available for rhenium and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Two Cases of 188Re Microspheres for Inoperable Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Quality of Life; Radioisotopes; Rhenium; Treatment Outcome | 2019 |
Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First
Topics: Animals; Carcinoma, Hepatocellular; Disease Models, Animal; Drug Carriers; Embolization, Therapeutic; Humans; In Vivo Dosimetry; Liver Neoplasms; Microspheres; Polyesters; Radioisotopes; Radiotherapy; Rats, Sprague-Dawley; Rhenium; Treatment Outcome | 2019 |
Therapeutic efficacy of 188Re-MN-16ET lipiodol in an animal model of hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Disease Models, Animal; Ethiodized Oil; Glycine; Liver Neoplasms; Male; Palmitic Acids; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rhenium; Survival Rate; Treatment Outcome; Tumor Burden | 2013 |
In vitro demonstration of synergy/additivity between (188)rhenium and sorafenib on hepatoma lines: preliminary results.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Combined Modality Therapy; Humans; In Vitro Techniques; Liver Neoplasms; Mice; Niacinamide; Phenylurea Compounds; Radioisotopes; Rhenium; Sorafenib | 2013 |
Preparation and therapeutic evaluation of (188)Re-thermogelling emulsion in rat model of hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Drug Combinations; Emulsions; Hydrogels; Iodized Oil; Liver Neoplasms, Experimental; Male; Organometallic Compounds; Polyethylene Glycols; Polyglactin 910; Radioisotopes; Rats; Rats, Sprague-Dawley; Rhenium; Survival Analysis; Tissue Distribution | 2014 |
Preparation and imaging of rhenium-188 labeled human serum albumin microsphere in orthotopic hepatoma rats.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Contrast Media; Humans; Isotope Labeling; Liver Neoplasms; Male; Microspheres; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rhenium; Serum Albumin; Treatment Outcome | 2015 |
Therapeutic and scintigraphic applications of polymeric micelles: combination of chemotherapy and radiotherapy in hepatocellular carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Doxorubicin; Drug Delivery Systems; Female; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Polymers; Radiopharmaceuticals; Rhenium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Xenograft Model Antitumor Assays | 2015 |
Preparation, characterization and evaluation of (186) Re-idarubicin: a novel agent for diagnosis and treatment of hepatocellular carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Topoisomerases, Type II; Humans; Idarubicin; Liver Neoplasms; Mice; Molecular Docking Simulation; Protein Binding; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution; Topoisomerase II Inhibitors | 2016 |
68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies.
Topics: Animals; Carcinoma, Hepatocellular; Gallium Radioisotopes; Injections, Intra-Arterial; Isotope Labeling; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rats; Rats, Wistar; Rhenium; Starch; Theranostic Nanomedicine; Tissue Distribution | 2016 |
Imaging, biodistribution and efficacy evaluation of
Topics: Animals; Apoptosis; Capsules; Carcinoma, Hepatocellular; Cell Line, Tumor; Injections, Intra-Arterial; Liver Neoplasms; Male; Organ Specificity; Radioisotopes; Radiopharmaceuticals; Rats, Inbred F344; Rhenium; Serum Albumin; Single Photon Emission Computed Tomography Computed Tomography; Theranostic Nanomedicine; Tissue Distribution; Treatment Outcome; Tumor Burden; Ultrasonography | 2017 |
Biokinetic and dosimetric studies of 188Re-hyaluronic acid: a new radiopharmaceutical for treatment of hepatocellular carcinoma.
Topics: Animals; Blood Proteins; Carcinoma, Hepatocellular; Female; Humans; Hyaluronic Acid; Isotope Labeling; Liver; Liver Neoplasms; Maximum Tolerated Dose; Mice; Radioisotopes; Radiometry; Radiopharmaceuticals; Rhenium; Tissue Distribution | 2009 |
Evaluating the potential of (188)Re-ECD/lipiodol as a therapeutic radiopharmaceutical by intratumoral injection for hepatoma treatment.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Injections, Intralesional; Iodized Oil; Liver Neoplasms; Male; Neoplasm Transplantation; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rhenium; Treatment Outcome | 2009 |
Therapeutic 188Re-lanreotide: determination of radiopharmacokinetic parameters in rats.
Topics: Animals; Antineoplastic Agents; Bone and Bones; Carcinoma, Hepatocellular; Half-Life; Liver; Liver Neoplasms; Male; Muscles; Peptides, Cyclic; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Reference Values; Rhenium; Somatostatin; Tissue Distribution | 2010 |
Lipid nanocapsules loaded with rhenium-188 reduce tumor progression in a rat hepatocellular carcinoma model.
Topics: Animals; Carcinoma, Hepatocellular; Catheterization; Disease Models, Animal; Disease Progression; Kinetics; Lipids; Liver Neoplasms; Magnetic Resonance Imaging; Male; Nanocapsules; Radioisotopes; Rats; Rats, Wistar; Rhenium; Survival Analysis; Tissue Distribution; Transaminases; Tumor Burden; Vascular Endothelial Growth Factor A | 2011 |
Sodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene delivery.
Topics: Adenoviridae; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Genetic Therapy; Hep G2 Cells; Humans; Iodine Radioisotopes; Liver Neoplasms; Mice; Mice, Nude; Promoter Regions, Genetic; Radioisotopes; Rhenium; RNA, Messenger; Symporters; Transfection; Transplantation, Heterologous | 2011 |
Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Coordination Complexes; Disease Models, Animal; Ethiodized Oil; Glycine; Liver Neoplasms; Male; Palmitic Acids; Radiochemistry; Radioisotopes; Rats; Rhenium; Stearates; Tomography, Emission-Computed, Single-Photon | 2011 |
Reduction of β-radiation exposure during preparation of 188Re-labelled Lipiodol for hepatocellular carcinoma treatment.
Topics: Antineoplastic Agents; Automation; Beta Particles; Carcinoma, Hepatocellular; Ethiodized Oil; Fingers; Humans; Liver Neoplasms; Occupational Exposure; Protective Devices; Radiation Injuries; Radiation Protection; Radioisotopes; Rhenium | 2012 |
Evaluation of S-values and dose distributions for (90)Y, (131)I, (166)Ho, and (188)Re in seven lobes of the rat liver.
Topics: Animals; Carcinoma, Hepatocellular; Electrons; Holmium; Iodine Radioisotopes; Liver; Liver Neoplasms; Monte Carlo Method; Photons; Radiation Dosage; Rats; Rats, Sprague-Dawley; Rhenium; Yttrium Radioisotopes | 2012 |
A comparison of Re-188-MN-16ET-lipiodol and transcatheter arterial chemoembolization in the treatment of hepatoma: an animal study.
Topics: Animals; Carcinoma, Hepatocellular; Catheters; Chemoembolization, Therapeutic; Ethiodized Oil; Glycine; Liver Neoplasms; Male; Palmitic Acids; Radioisotopes; Rats; Rats, Sprague-Dawley; Rhenium; Tumor Burden | 2013 |
Direct injection of (188)Re-microspheres in the treatment of hepatocellular carcinoma: compared with traditional percutaneous ethanol injection: an animal study.
Topics: Animals; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Disease Models, Animal; Liver Neoplasms; Microspheres; Rabbits; Radionuclide Imaging; Rhenium; Treatment Outcome | 2005 |
Description and technical pitfalls of a hepatoma model and of intra-arterial injection of radiolabelled lipiodol in the rat.
Topics: Anesthetics; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Models, Animal; Female; Injections, Intra-Arterial; Iodine Radioisotopes; Iodized Oil; Isoflurane; Ketamine; Radioisotopes; Rats; Rats, Sprague-Dawley; Rhenium; Time Factors | 2005 |
Management of multiple intrahepatic recurrences after radiofrequency ablation of hepatocellular carcinoma with rhenium-188-HDD-lipiodol.
Topics: Adult; Carcinoma, Hepatocellular; Catheter Ablation; Humans; Iodized Oil; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Radioisotopes; Radiometry; Rhenium; Tomography, X-Ray Computed | 2006 |
Management of postsurgical recurrence of hepatocellular carcinoma with rhenium 188-HDD labeled iodized oil.
Topics: Adult; Carcinoma, Hepatocellular; Contrast Media; Humans; Iodized Oil; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Prognosis; Radioisotopes; Rhenium | 2006 |
Assessment of supra-additive effects of cytotoxic drugs and low dose rate irradiation in an in vitro model for hepatocellular carcinoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cobalt Radioisotopes; Combined Modality Therapy; Deoxycytidine; Dose-Response Relationship, Radiation; Fluorouracil; Gamma Rays; Gemcitabine; Glucose Transporter Type 1; Humans; Rhenium; Topotecan | 2006 |
Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb 188Re-HAb18.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Hepatocellular; Immunoglobulin Fab Fragments; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Radioisotopes; Rhenium; Tissue Distribution | 2002 |
Re: 188rhenium-TDD-lipiodol in treatment of inoperable primary hepatocellular carcinoma--a case report.
Topics: Carcinoma, Hepatocellular; Follow-Up Studies; Humans; Iodized Oil; Isotopes; Liver Neoplasms; Palliative Care; Radiopharmaceuticals; Rhenium; Terminally Ill; Treatment Outcome | 2002 |